Pfizer Ltd is engaged in manufacturing, marketing, trading and export of pharmaceutical products. It manufactures products through its own facility and also has various independent contract/ third party manufacturers based across the country and sells its products through independent distributors primarily in India.
It is the 3rd largest multinational pharmaceutical company in India.
Financial Results:
Pfizer Ltd reported Revenues for Q1FY24 of ₹531.00 Crores down from ₹593.00 Crore year on year, a fall of 10.46%.
Total Expenses for Q1FY24 of ₹440.00 Crores up from ₹432.00 Crores year on year, a rise of 1.85%.
Consolidated Net Profit of ₹94.00 Crores up 184.85% from ₹33.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹20.44, up 187.08% from ₹7.12 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.